Page last updated: 2024-11-02

pifithrin and Benign Neoplasms

pifithrin has been researched along with Benign Neoplasms in 8 studies

pifithrin: a tetrahydrobenzothiazol; inhibitor of P53 that protects mice from the side effects of cancer therapy; structure in first source

Research Excerpts

ExcerptRelevanceReference
"When the cancer cells were cocultured with the CAF aggregates incorporating GM-PFT, the invasion rate of cancer cells was significantly high compared with CAF aggregates or CAF aggregates incorporating GM with or without the same dose of free PFT as well as two-dimension cultured CAF with or without the same dose of PFT."1.51A Cancer Invasion Model Combined with Cancer-Associated Fibroblasts Aggregates Incorporating Gelatin Hydrogel Microspheres Containing a p53 Inhibitor. ( Makino, K; Nii, T; Tabata, Y, 2019)
"We found that ADR treatment of cancer cells in HG increased autophagy, as displayed by greater LC3II accumulation and p62 degradation compared to ADR-treated cells in low glucose."1.46p53-Dependent PUMA to DRAM antagonistic interplay as a key molecular switch in cell-fate decision in normal/high glucose conditions. ( Baldari, S; Cirone, M; D'Orazi, G; Garufi, A; Pistritto, G; Toietta, G, 2017)
"Chemotherapy and radiation therapy for cancer often have severe side effects that limit their efficacy."1.30A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. ( Chernov, MV; Christov-Tselkov, K; Coon, JS; Gudkov, AV; Komarov, PG; Komarova, EA; Kondratov, RV, 1999)

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (25.00)18.2507
2000's2 (25.00)29.6817
2010's4 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nii, T1
Makino, K1
Tabata, Y1
Garufi, A1
Pistritto, G1
Baldari, S1
Toietta, G1
Cirone, M1
D'Orazi, G1
Yang, A1
Liu, F1
Guan, B1
Luo, Z1
Lin, J1
Fang, W1
Liu, L1
Zuo, W1
Leonova, KI1
Shneyder, J1
Antoch, MP1
Toshkov, IA1
Novototskaya, LR1
Komarov, PG2
Komarova, EA4
Gudkov, AV4
Kondratov, RV1
Christov-Tselkov, K1
Coon, JS1
Chernov, MV1
Ferber, D1

Reviews

2 reviews available for pifithrin and Benign Neoplasms

ArticleYear
Dangerous habits of a security guard: the two faces of p53 as a drug target.
    Human molecular genetics, 2007, Apr-15, Volume: 16 Spec No 1

    Topics: Animals; Apoptosis; Benzothiazoles; Gene Expression Regulation; Genes, p53; Humans; Neoplasms; Tolue

2007
Suppression of p53: a new approach to overcome side effects of antitumor therapy.
    Biochemistry. Biokhimiia, 2000, Volume: 65, Issue:1

    Topics: Animals; Antineoplastic Agents; Apoptosis; Benzothiazoles; Gene Expression Regulation, Neoplastic; G

2000

Other Studies

6 other studies available for pifithrin and Benign Neoplasms

ArticleYear
A Cancer Invasion Model Combined with Cancer-Associated Fibroblasts Aggregates Incorporating Gelatin Hydrogel Microspheres Containing a p53 Inhibitor.
    Tissue engineering. Part C, Methods, 2019, Volume: 25, Issue:12

    Topics: Benzothiazoles; Cancer-Associated Fibroblasts; Cell Line, Tumor; Gelatin; Humans; Hydrogels; Microsp

2019
p53-Dependent PUMA to DRAM antagonistic interplay as a key molecular switch in cell-fate decision in normal/high glucose conditions.
    Journal of experimental & clinical cancer research : CR, 2017, 09-11, Volume: 36, Issue:1

    Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Autophagy-Related Protein 5; Benzothia

2017
p53 induces miR-199a-3p to suppress mechanistic target of rapamycin activation in cisplatin-induced acute kidney injury.
    Journal of cellular biochemistry, 2019, Volume: 120, Issue:10

    Topics: Acute Kidney Injury; Animals; Apoptosis; Benzothiazoles; Cell Proliferation; Cisplatin; Drug Resista

2019
A small molecule inhibitor of p53 stimulates amplification of hematopoietic stem cells but does not promote tumor development in mice.
    Cell cycle (Georgetown, Tex.), 2010, Apr-01, Volume: 9, Issue:7

    Topics: Animals; Benzothiazoles; Cell Proliferation; Cells, Cultured; Gamma Rays; Hematopoietic Stem Cells;

2010
A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy.
    Science (New York, N.Y.), 1999, Sep-10, Volume: 285, Issue:5434

    Topics: Animals; Antineoplastic Agents; Apoptosis; Benzothiazoles; Cell Division; Cell Line; Cell Nucleus; C

1999
Cancer research. A new way to combat therapy side effects.
    Science (New York, N.Y.), 1999, Sep-10, Volume: 285, Issue:5434

    Topics: Animals; Antineoplastic Agents; Apoptosis; Benzothiazoles; Cell Division; Cells, Cultured; Drug Eval

1999